205 related articles for article (PubMed ID: 34844991)
1. MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage.
Feng H; Shen H; Robeson MJ; Wu YH; Wu HK; Chen GJ; Zhang S; Xie P; Jin L; He Y; Wang Y; Lv F; Hu X; Zhang Y; Xiao RP
Diabetes; 2022 Feb; 71(2):298-314. PubMed ID: 34844991
[TBL] [Abstract][Full Text] [Related]
2. Blocking MG53
Lv F; Wang Y; Shan D; Guo S; Chen G; Jin L; Zheng W; Feng H; Zeng X; Zhang S; Zhang Y; Hu X; Xiao RP
Circ Res; 2022 Dec; 131(12):962-976. PubMed ID: 36337049
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H
Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP
Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.
Liu J; Zhu H; Zheng Y; Xu Z; Li L; Tan T; Park KH; Hou J; Zhang C; Li D; Li R; Liu Z; Weisleder N; Zhu D; Lin P; Ma J
J Mol Cell Cardiol; 2015 Mar; 80():10-19. PubMed ID: 25533937
[TBL] [Abstract][Full Text] [Related]
6. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST
Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476
[TBL] [Abstract][Full Text] [Related]
7. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.
Song R; Peng W; Zhang Y; Lv F; Wu HK; Guo J; Cao Y; Pi Y; Zhang X; Jin L; Zhang M; Jiang P; Liu F; Meng S; Zhang X; Jiang P; Cao CM; Xiao RP
Nature; 2013 Feb; 494(7437):375-9. PubMed ID: 23354051
[TBL] [Abstract][Full Text] [Related]
8. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.
Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP
Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741
[TBL] [Abstract][Full Text] [Related]
9. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
10. MG53 and disordered metabolism in striated muscle.
Hu X; Xiao RP
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1984-1990. PubMed ID: 29017896
[TBL] [Abstract][Full Text] [Related]
11. MG53: Biological Function and Potential as a Therapeutic Target.
Zhang Y; Wu HK; Lv F; Xiao RP
Mol Pharmacol; 2017 Sep; 92(3):211-218. PubMed ID: 28432201
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair.
Wang X; Xie W; Zhang Y; Lin P; Han L; Han P; Wang Y; Chen Z; Ji G; Zheng M; Weisleder N; Xiao RP; Takeshima H; Ma J; Cheng H
Circ Res; 2010 Jul; 107(1):76-83. PubMed ID: 20466981
[TBL] [Abstract][Full Text] [Related]
14. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
Zhang Y; Lv F; Jin L; Peng W; Song R; Ma J; Cao CM; Xiao RP
Cardiovasc Res; 2011 Jul; 91(1):108-15. PubMed ID: 21285295
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
17. Advances in the Study of MG53 in Cardiovascular Disease.
Liu SM; Zhao Q; Li WJ; Zhao JQ
Int J Gen Med; 2023; 16():6073-6082. PubMed ID: 38152078
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
19. Reduction of SIRT1 blunts the protective effects of ischemic post-conditioning in diabetic mice by impairing the Akt signaling pathway.
Ding M; Hu L; Yang H; Gao C; Zeng K; Yu M; Feng J; Qiu J; Liu C; Fu F; Li Y
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1677-1689. PubMed ID: 30954556
[TBL] [Abstract][Full Text] [Related]
20. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
Li Z; Dai R; Chen M; Huang L; Zhu K; Li M; Zhu W; Li Y; Xie N; Li J; Wang L; Lan F; Cao CM
Cardiovasc Res; 2023 Nov; 119(14):2421-2440. PubMed ID: 37527538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
